Respiratory Muscle Endurance Training in Obese Patients

Obesity Clinical Trial

Official title:

Respiratory Muscle Endurance Training in Obese Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01026155
• Other study ID #: Respob
• Status: Completed
• Phase: N/A
• First received: December 3, 2009
• Last updated: December 3, 2009

Study information

• Verified date: December 2009
• Source: Fondation Edith Seltzer
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: INSERM
• Study type: Interventional

Clinical Trial Summary

Obese patients are known to have increased work of breathing inducing dyspnea, exercise intolerance and impaired quality of life. Respiratory muscle training is known to increase respiratory muscle capacity, reduce dyspnoea and improve exercise performance in healthy subjects and respiratory patients. The investigators hypothesized that Respiratory muscle training would reduce dyspnoea, increase exercise tolerance and quality of life in obese patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Obese patients (BMI > 30 kg/m2), without respiratory pathology (VEMS > 80% predicted, VEMS/CV > 80%)

• men or women

• age between 18 and 60 years old

Exclusion Criteria:

• Respiratory, cardiovascular, musculoskeletal diseases

• Alcoholism

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Obesity

Intervention

Other:
• Respiratory muscle training
Respiratory muscle endurance training by means of isocapnic voluntary hyperpnoea

Locations

Country	Name	City	State
France	Centre Bois de l'Ours	Briançon

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Edith Seltzer

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dyspnea at rest and during exercise			No
Secondary	Exercise performance (6-min walking distance) Quality of life (SF36 questionnaire)			No